Cargando…

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study

Detalles Bibliográficos
Autores principales: Blanchard, A., Hewko, S., Somayaji, R., Cogen, J., Hernandez, R., Stephenson, A., Yau, Y., Julien, J., Quon, B., Downey, D., Hoffman, L., Waters, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518460/
http://dx.doi.org/10.1016/S1569-1993(21)01914-7
_version_ 1784584228551262208
author Blanchard, A.
Hewko, S.
Somayaji, R.
Cogen, J.
Hernandez, R.
Stephenson, A.
Yau, Y.
Julien, J.
Quon, B.
Downey, D.
Hoffman, L.
Waters, V.
author_facet Blanchard, A.
Hewko, S.
Somayaji, R.
Cogen, J.
Hernandez, R.
Stephenson, A.
Yau, Y.
Julien, J.
Quon, B.
Downey, D.
Hoffman, L.
Waters, V.
author_sort Blanchard, A.
collection PubMed
description
format Online
Article
Text
id pubmed-8518460
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-85184602021-10-15 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study Blanchard, A. Hewko, S. Somayaji, R. Cogen, J. Hernandez, R. Stephenson, A. Yau, Y. Julien, J. Quon, B. Downey, D. Hoffman, L. Waters, V. J Cyst Fibros Posters European Cystic Fibrosis Society. 2021-11 2021-10-15 /pmc/articles/PMC8518460/ http://dx.doi.org/10.1016/S1569-1993(21)01914-7 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Posters
Blanchard, A.
Hewko, S.
Somayaji, R.
Cogen, J.
Hernandez, R.
Stephenson, A.
Yau, Y.
Julien, J.
Quon, B.
Downey, D.
Hoffman, L.
Waters, V.
490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
title 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
title_full 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
title_fullStr 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
title_full_unstemmed 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
title_short 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
title_sort 490: a prospective study to evaluate serologic and immune responses to sars-cov-2 infection in persons living with cystic fibrosis: canadian arm of the car-cf study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518460/
http://dx.doi.org/10.1016/S1569-1993(21)01914-7
work_keys_str_mv AT blancharda 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT hewkos 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT somayajir 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT cogenj 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT hernandezr 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT stephensona 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT yauy 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT julienj 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT quonb 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT downeyd 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT hoffmanl 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy
AT watersv 490aprospectivestudytoevaluateserologicandimmuneresponsestosarscov2infectioninpersonslivingwithcysticfibrosiscanadianarmofthecarcfstudy